Planning ahead for ATTR-CM progression: What to expect
Fact-checked by Transthyretin amyloid cardiomyopathy (ATTR-CM) is a progressive disease in which improperly folded transthyretin (TTR) proteins accumulate in the heart and damage it. Typical ATTR-CM progression is characterized by declining heart function and quality of life.
Although symptoms may be mild or absent in early stages of the disease, the protein clumps, called amyloid deposits, increasingly interfere with heart function. Left untreated, ATTR-CM typically leads to heart failure and related complications.
However, the availability of new treatments has changed the outlook for many with ATTR-CM. If started early, these therapies can limit irreversible heart damage, delaying disease progression, and making everyday life with ATTR-CM more manageable.
Each person is unique and, as with most diseases, ATTR-CM doesn’t look exactly the same for everyone. Nevertheless, understanding the typical progression of this heart disease will help you anticipate what to expect with ATTR-CM over time.
Changes you might notice as the condition progresses
In the very early stages of ATTR-CM, you might not have any obvious signs of a heart problem. The earliest symptoms of the disease may sometimes be associated with TTR buildup outside the heart.
These symptoms may occur several years before the disease is diagnosed, and could include carpal tunnel syndrome (a condition caused by pressure on the median nerve in the carpal tunnel of the wrist) or symptoms of nerve damage.
As heart damage progresses, you might start to notice subtle symptoms such as unexplained shortness of breath, which is often an early sign of heart failure. You might feel it becomes more difficult to exercise or that you become fatigued easily.
Worsening of these symptoms can be an early sign of ATTR-CM progression. For example, shortness of breath may at first only be noticeable when you’re active, but later might occur even when you’re sitting still. However, some people remain asymptomatic even when heart damage is accumulating.
Over time, other symptoms of heart failure may develop, such as:
- coughing or wheezing
- swelling or bloating
- confusion and difficulty thinking
- increased heart rate
- palpitations or heart rhythm changes
Defining ATTR-CM progression
There are a few different ATTR-CM staging systems that have been developed to assess disease progression and predict survival.
The Mayo Clinic and the U.K. National Amyloidosis Centre (NAC) systems define three ATTR-CM stages based on certain blood biomarkers. The Columbia system, meanwhile, predicts outcomes based on Mayo Clinic or NAC scores, along with daily doses of heart medication and functional status.
In a 2026 report, experts proposed a system defining disease progression based on six metrics across three categories:
- clinical progression: increasing clinical needs (including hospitalizations, heart failure medications)
- biomarker progression: signs of worsening organ damage in blood tests (including increasing NT-proBNP, a marker of heart failure, or decreasing eGFR, a marker of kidney function)
- functional progression: increasing impact on daily living (including on exercise capacity and quality of life)
Under this system, these metrics should be evaluated every year. If at least two metrics meet predefined thresholds of change from the previous year, the disease is considered to have progressed.
While the symptoms of ATTR-CM tend to worsen as more amyloid accumulates, the exact relationship between amyloid buildup and other indicators of disease progression is complex and not completely understood.
Monitoring your health and symptoms
Tracking symptoms of ATTR-CM over time can help healthcare providers understand your treatment needs and identify potential signs of progression early. As such, it’s a good idea to keep a symptom log that includes:
- what precedes symptoms
- which symptoms emerge
- how long the symptoms last
- what, if anything, helps resolve symptoms
In some cases, it might also be helpful to monitor blood pressure and blood oxygen levels in between clinic visits, which you can do at home with relatively inexpensive equipment. Your cardiologist can tell you if this makes sense in your case.
Treatment and management strategies
In the U.S., three medications are approved for the treatment of ATTR-CM. These work in different ways to slow amyloid buildup, potentially delaying disease progression.
In addition to these disease-modifying therapies, heart amyloidosis management may include medications and other strategies to ease specific symptoms and support overall health.
Together, disease-modifying therapies and supportive care can help improve your quality of life with ATTR-CM and allow you to be as healthy and active as possible at every disease stage.
Planning ahead for daily life
Careful planning and lifestyle changes can also help make living with ATTR-CM easier. This can include:
- eating a heart-healthy diet, and regulating salt and water intake to manage certain symptoms of heart failure
- participating in safe, regular exercise
- controlled pacing of activities and relaxation practices to combat fatigue
Managing fatigue and shortness of breath in ATTR-CM can be challenging. These symptoms make it more difficult to exercise, but staying active is still recommended. It’s a good idea to talk with your healthcare providers about what forms of exercise will work best for you.
Emotional and social support
Living with a progressive heart disease can be stressful, so planning for heart amyloidosis should also include emotional and social support.
Support groups may provide an opportunity for people with ATTR-CM and their caregivers to connect with others around shared experiences. Individual talk therapy or other forms of counseling can also help you process changes in daily life and develop healthy coping strategies as the disease progresses.
Organizations like the Amyloidosis Research Consortium and the Amyloidosis Foundation provide support resources for ATTR-CM patients.
Preparing for the future
Although treatment can delay ATTR-CM progression and improve outcomes, it is not a guarantee that the disease will never progress. Some people will still experience worsening symptoms as heart failure advances.
Preparing for advanced heart disease at earlier disease stages can help ensure that you’re ready for whatever comes next and that all members of your support team, including caregivers and healthcare providers, are on the same page.
- Safety planning: Consider making accommodations in living spaces or having walking aids available to help prevent falls and make it easier to move around.
- Emergency planning: Develop an emergency action plan to consolidate contact information and medical details in one place so they are easily accessible.
- Financial planning: Review your finances and determine which medical costs you can afford. Discuss with your care team possible pathways for financial support or aid.
- Care planning: Talk with your caregivers and healthcare providers about the types of health-related decisions that may arise in the future, including those related to supportive or end-of-life care.
You can write down your care preferences in the form of advance directives. These legal documents ensure you get the care you want if you are unable to advocate for yourself at any point in the future.
They include living wills, which detail end-of-life wishes, and power-of-attorney documents, which allow you to designate a person who can make decisions on your behalf.
This process can be emotionally challenging, so it’s important to rely on your social support systems and seek mental health support if you need it.
Amyloidosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis, or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
